The Readiness of Biosimilars in Multiple Sclero...

By HEOR Staff Writer

September 19, 2024

Introduction In the complex landscape of Multiple Sclerosis (MS) treatment, biosimilars have begun to play a crucial role. These
Artificial Intelligence in Elderly Care: Ethical and Responsible Adoption
Healthcare System Responses to Ageing Populations
Elderly Technology Acceptance: Enhancing Health and Independence
Remote Health Assessments with Multimodal Technologies
A Comparative Study on PRO Symptom Monitoring Approaches
Expanding the Value Metrics in Fixed-Budget Healthcare Systems
Addressing the Challenges of Value Attribution in Combination Therapies
Gaps in Psoriasis Care: A Global Perspective
Disparities in HPV Vaccination by Health Care Facility Type
The Urgent Need for Measles and Rubella Eradication
Global Disparities in Pneumonia Vaccine Access
Revealing the Hidden Impact: Family Spillover Effects